NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, announced today that Barry Weiner, President, will make a presentation on Tuesday, November 28, 2006, at 4:30P.M. (E.T.) at the Lazard Capital Markets Third Annual Life Sciences Conference, being held at the New York Palace Hotel in New York City.
